Laparoscopic Combined Hypo Gastric Neural Plexus Block and Uterosacral Nerve Block for Patients With Chronic Idiopathic Pelvic Pain
Unknown statusNot applicableNCT05345782
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Often the etiology of chronic pelvic pain is not clear, as there are many disorders of the reproductive tract, gastrointestinal system, urological organs, musculoskeletal system, and psych neurological system that may be associated with chronic pelvic pain. An effective treatment for this condition has evaded the medical profession for centuries. Even today only 20-25% patients respond to conservative management.5 When such treatment fails, a diagnostic laparoscopy is performed.1, 3, 6 the cause of the pain is not always obvious as no pathology is seen in 40-60% of the cases.1
Study details
- Official title
- Laparoscopic Combined Hypo Gastric Neural Plexus Block and Uterosacral Nerve Block for Patients With Chronic Idiopathic Pelvic Pain
- Conditions
- Chronic Idiopathic Pain Syndrome
- Interventions
- Drug: MARCAINE AND BETAMETHAZONE 1
- Drug: MARCAINE AND BETAMETHAZONE 2
- Sponsor
- Ain Shams University
- Start date
- 2022-04-20
- Primary completion
- 2023-04-26
- Sex
- All
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * • Age 18 to 50 years old. * American Society of Anesthesiologists physical status (ASA-PS) I and II Patients. * Sex: female. * Patients scheduled for elective laparoscopy for diagnosis of the cause of chronic pelvic pain. Exclusion Criteria: * • Patient refusal. * Patients on chronic pain medications. * ASA III or worse clinical condition. * Intra-abdominal infection. * Allergy to any of the study medications.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05345782